Camazepam
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Camazepam.svg | |
| Image:Camazepam3d.png | |
| Camazepam
| |
| Systematic (IUPAC) name | |
| (9-chloro-2-methyl-3-oxo-6-phenyl- 2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-4-yl) N,N-dimethylcarbamate | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H18ClN3O3 |
| Mol. mass | 371.8 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Camazepam (marketed under the brand names Albego, Limpidon, and Paxor) is the dimethyl carbamate salt of temazepam, a metabolite of diazepam. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Compared to temazepam, camazepam has shown greater anticonvulsant properties, roughly equal anxiolytic properties, and less sedative and amnestic properties.
